Navigation Links
IDM Pharma Reports 2008 Financial Results
Date:3/31/2009

000) Net loss $(1,857,000) $(2,682,000) $(18,606,000) $(18,350,000) Weighted average number of shares outstanding 25,451,015 25,146,206 25,265,558 21,075,738 Basic and diluted loss per share $(0.07) $(0.11) $(0.74) $(0.87) Comprehensive loss: Net loss $(1,857,000) $(2,682,000) $(18,606,000) $(18,350,000) Other comprehensive (loss) gain (99,000) 1,094,000 (617,000) 2,041,000 $(1,956,000) $(1,588,000) $(19,223,000) $(16,309,000)
                                     IDM PHARMA, INC.
                           CONDENSED CONSOLIDATED BALANCE SHEETS
                                        (unaudited)

                                              December 31,      December 31,
                                                    2008              2007

    ASSETS
    Current assets:
     Cash and cash equivalents                 $12,752,000       $28,382,000
     Other current assets                          755,000         4,786,000
    Total current assets                        13,507,000        33,168,000

    Property and equipment, net                    242,000           513,000
    Patents, trademarks and other licenses, net  2,642,000         2,734,000
    Goodwill                                     2,812,000         2,812,000
    Other long-term assets                         473,000           832,000
    Total Assets                               $19,676,000       $40,059,000

    LIABILITIES AND STOCKHOLDERS' EQUITY
     Common stock warrants                      $3,522,000          $450,000
     Other current liabilities                   5,794,000        11,712,000
     Other liabilities                           1,211,000         1,874,000
     Stockholders' equity                        9,149,000        26,023,000
    Total liabilities and
'/>"/>
SOURCE IDM Pharma, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related biology technology :

1. Endo Pharmaceuticals Appoints Dr. Nancy Hutson to Board of Directors
2. The MedZilla Report: Febraury 2009 Employment Outlook for Biotech/Pharma/Health
3. Recent Graduates Finding BioTech & Pharmaceutical Jobs Easier Than Ever With The Launch of CampusRXBio
4. VIA Pharmaceuticals Complies With NASDAQ Rules
5. Catalyst Pharmaceutical Partners Reports Fourth Quarter and Year-End 2008 Financial Results
6. Anadys Pharmaceuticals to Present at Future Leaders in the Biotech Industry
7. Cadence Pharmaceuticals CEO Theodore Schroeder to Present at BioCentury Publications Inc. Future Leaders in the Biotech Industry Conference in New York on April 2, 2009
8. WuXi PharmaTech Announces Fourth-Quarter and Full-Year 2008 Results
9. Trubion Pharmaceuticals, Inc. Announces Initiation of Phase 1 Study of SBI-087 for the Treatment of Systemic Lupus Erythematosus (SLE)
10. Isis Pharmaceuticals to Present at the 4th Annual Citi Biotech Day
11. ADVENTRX Pharmaceuticals, Inc. Reports Fourth Quarter and Full Year 2008 Financial Results
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 2014 Connecticut Center for Advanced Technology, ... East Hartford, Conn., was awarded a Rural Business Enterprise ... project that will determine the feasibility of implementing an ... USDA Rural Development provided $53,000 for CCAT under the ... phase of the feasibility study in fiscal year 2014. ...
(Date:7/30/2014)... Henderson, CA (PRWEB) July 30, 2014 ... hosting presentations of leading Immunologists, Principle Investigators, scientists ... Charles J Malemud, Professor at Case Western ... be delivering his keynote address on “The ... TNF-a in production of matrix metalloproteinase-9”. Arya Biragyn, ...
(Date:7/29/2014)... Dallas, Texas (PRWEB) July 30, 2014 ... in Private Equity and Venture Capital Funding” report ... factors shaping the private equity and venture capital ... that these are expected to have significant impact ... the US and globally. Furthermore, the report identifies ...
(Date:7/29/2014)... July 29, 2014   Sequenom, Inc. (NASDAQ: ... provides innovative genetic analysis solutions, and Mayo Medical ... services in the United States , ... patents and applications. "We have great appreciation ... care, and we welcome the opportunity to partner with ...
Breaking Biology Technology:USDA Grant Funds Second Phase of Bio-Energy Research Community Economic Development in CT 2USDA Grant Funds Second Phase of Bio-Energy Research Community Economic Development in CT 3Unveiling Breakthroughs in Clinical & Cellular Immunology 2Unveiling Breakthroughs in Clinical & Cellular Immunology 3Strategic Trends of Biotech Investment Industry (Private Equity and Venture Capital Funding) in New Report Available at MarketOptimizer.org 2Strategic Trends of Biotech Investment Industry (Private Equity and Venture Capital Funding) in New Report Available at MarketOptimizer.org 3Strategic Trends of Biotech Investment Industry (Private Equity and Venture Capital Funding) in New Report Available at MarketOptimizer.org 4Sequenom Enters Into License Agreement With Mayo Medical Laboratories 2Sequenom Enters Into License Agreement With Mayo Medical Laboratories 3Sequenom Enters Into License Agreement With Mayo Medical Laboratories 4
... (OTC.BB: FPMI), a biopharmaceutical company developing the ... of its official stock ticker symbol from CEWM to ... previously announced FluoroPharma Inc. merger with CEWM. ... biopharmaceutical company engaged in the discovery and development of ...
... N.C., June 3, 2011 Recent biopharmaceutical product launches ... the cardiovascular therapeutic area. Faced with a continually evolving ... the biggest role in the current launch environment. ... explores the pivotal success factors and failure points facing ...
... 3, 2011 LifeVantage Corporation (OTCBB: ... science-based therapy for the reduction of oxidative stress ... that a new peer-reviewed review article involving Protandim® ... Research .   (Logo:   http://photos.prnewswire.com/prnh/20090930/LIFEVANTAGELOGO ...
Cached Biology Technology:FluoroPharma Medical Announces Stock Ticker Symbol Change 2Creating a Road Map for Successful Cardiovascular New Product Launch 2LifeVantage's Nrf2 Activator Reviewed for Tumor Prevention and Suppression in New Peer-Reviewed Article 2LifeVantage's Nrf2 Activator Reviewed for Tumor Prevention and Suppression in New Peer-Reviewed Article 3LifeVantage's Nrf2 Activator Reviewed for Tumor Prevention and Suppression in New Peer-Reviewed Article 4LifeVantage's Nrf2 Activator Reviewed for Tumor Prevention and Suppression in New Peer-Reviewed Article 5
(Date:7/29/2014)... world of science, researchers sometimes need to get ... did just that to study the impacts of ... coral reef ecosystems at two remote locations in ... animal tracking and computer simulation, McCauley, an assistant ... Marine Biology, and his colleagues sought to understand ...
(Date:7/29/2014)... plays a major role in locomotion. Swimming microorganisms, such ... inertial forces compared to the viscous forces exerted by ... a major challenge. Now, scientists have found that the ... opposite to that induced by a viscoelastic fluid. These ... by Franois Nadal from the Alternative Energies and Atomic ...
(Date:7/29/2014)... on the remote UK overseas territory of Ascension Island, ... undergoing something of a renaissance. , Writing in the ... University of Exeter and Ascension Island Government Conservation Department ... the remote South Atlantic outpost has increased by more ... 1970s. As many as 24,000 nests are now estimated ...
Breaking Biology News(10 mins):Underwater elephants 2Underwater elephants 3Optimum inertial self-propulsion design for snowman-like nanorobot 2Major turtle nesting beaches protected in 1 of the UK's far flung overseas territories 2
... Efforts on the Growing Issue of Identity Management , ... WASHINGTON , July ... today announced that it has expanded its mission to focus on the ... biometric and other technologies play an increasingly important role, has been deemed ...
... Having discovered a dramatic increase of an easy-to-detect enzyme ... prediabetes, Johns Hopkins scientists say the discovery could lead to ... the disease, before symptoms or complications occur and in time ... 22 in Diabetes , show the enzyme O-GlcNAcase is ...
... 8, 2010 A new system for the controlled ... team of University of Rhode Island chemical engineers using ... by non-invasive electromagnetic fields. The discovery by URI ... Yanjing Chen was published in the June issue of ...
Cached Biology News:The International Biometrics & Identification Association (IBIA) Sets New Course to Benefit Consumers, Businesses and Governments Across the Globe 2The International Biometrics & Identification Association (IBIA) Sets New Course to Benefit Consumers, Businesses and Governments Across the Globe 3Hopkins team discovers sweet way to detect prediabetes 2Researchers develop drug delivery system using nanoparticles triggered by electromagnetic field 2
Multi-enzyme complex containing a wide range of carbohydrases, including arabanase, cellulase,b-glucanase, hemi-cellulase and xylanase Patent/trademark/license (electronic): A product of Novozyme Cor...
... Biotin Streptavidin-HRP Systems provide rapid, precise ... antigens in frozen or paraffin-embedded tissue, ... systems also facilitate double or triple ... performed simultaneously with primary antibodies of ...
Miscellaneous: Versatile stain for staining RNA (bluish-purple), DNA (blue), proteins (red) and acid polysaccharides Assay: ~ 95 % Suitab tst: differential staining of nucleic acids and prote...
Screening test for the detection of Salmonella sp. by means of DNA amplification, subsequent molecular hybridization and detection on a microtitre plate....
Biology Products: